Phase 1 Interstitial Lung Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You have been diagnosed with, or doctors suspect you may have, pulmonary fibrosis (scarring of the lungs)
- You are willing and able to sign a consent form agreeing to take part in the study
Who may not be able to join:
- You are currently pregnant
- You are currently breastfeeding
- You have a known allergy to a substance called FAPI (confirm with trial site)
- You have any other health condition that the study doctor believes could interfere with your ability to take part safely and fully in the trial
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Zhaohui Zhu, MD, Peking Union Medical College Hospital
Phone: 86-13611093752
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Diagnostic value
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.